An 18-year-old male with a personal history of LLA-T in complete remission for 6 months after chemotherapy according to the PETHEMA LAL protocol - high risk/2003 (Vincristine, daunorubicin VA, prednisone plus intrathecal chemotherapy) and prednisone plus eye drops